Deleterious Impact of "High Normal" Glucose Levels and other Metabolic Syndrome Components on Arterial Endothelial Function and Intima-Media Thickness in Apparently Healthy Chinese Subjects: The CATHAY Study

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 24, Issue 4, 2004, Pages 739-743

  Thomas, G Neil ^a   Chook, Ping ^a   Qiao, Mu ^a   Huang, Xin S ^b   Leong, Hok C ^c   Celermajer, David S ^d   Woo, Kam Sang ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b Guangdong Provincial Traditional Chinese Medical Hospital   (China)

^c Macao Special Administrative Region of the People's Republic of China   (China)

^d ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Atherosclerosis; Diabetes mellitus; Epidemiology; Hypertension; Lipids

Indexed keywords

GLUCOSE; LIPID;

ADULT; AGED; ARTERY ENDOTHELIUM; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; B SCAN; BLOOD PRESSURE; BRACHIAL ARTERY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY; CHINESE; DIET RESTRICTION; DISEASE MARKER; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; LINEAR REGRESSION ANALYSIS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; VASODILATATION;

ADOLESCENT; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; BRACHIAL ARTERY; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; COHORT STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; HONG KONG; HUMANS; HYPERGLYCEMIA; LIPIDS; MACAO; MALE; METABOLIC SYNDROME X; MIDDLE AGED; REFERENCE VALUES; RISK FACTORS; TUNICA INTIMA; TUNICA MEDIA; VASODILATION;

EID: 1842475780     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000118015.26978.07     Document Type: Article

References (38)

1. Vogel RA, Corretti MC. Estrogens, progestins, and heart disease: can endothelial function divine the benefit? Circulation. 1998;97:1223-1226.
2. Zeiher AM, Drexler H, Wollschlõger H, Just H. Modulation of coronary vasomotor tone in humans: progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation. 1991;83: 391-401.
3. Quyyumi AA, Dakak N, Andrews NP, Husain S, Arora S, Gilligan DM, Panza JA, Cannon RO 3rd. Nitric oxide activity in the human coronary circulation: impact of risk factors for coronary atherosclerosis. J Clin Invest. 1995;95:1747-1755.
4. Vita JA, Treasure CB, Nabel EG, McLenachan JM, Fish RD, Yeung AC, Vekshtein VI, Selwyn AP, Ganz P. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation. 1990;81:491-497.
5. Schõchinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation. 2000;101:1899-1906.
6. Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes Jr DR, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation. 2000;101:948-954.
7. Enderle MD, Schroeder S, Ossen R, Meisner C, Baumbach A, Haering HU, Karsch KR, Pfohl M. Comparison of peripheral endothelial dysfunction and intimal media thickness in patients with suspected coronary artery disease. Heart. 1998;80:349-354.
8. Geroulakos G, O'Gorman D, Nicolaides A, Sheridan D, Elkeles R, Shaper AG. Carotid intima-media thickness: correlation with the British Regional Heart Study risk score. J Intern Med. 1994;235:431-433.
9. Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, Sharrett AR, Clegg LX. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol. 1997; 146:483-494.
10. Woo KS, Chook P, Lolin YI, Cheung ASP, Chan LT, Sun YY, Sanderson JE, Metreweli C, Celemajer DS. Hyperhomocysteinaemia is a risk factor for arterial endothelial dysfunction in humans. Circulation. 1997;96: 2542-2544.
11. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340:1111-1115.
12. Woo KS, McCrohon JA, Chook P, Adams MR, Robinson JT, McCredie RJ, Lam CW, Feng JZ, Celermajer DS. Chinese adults are less susceptible to age-related endothelial dysfunction than Caucasian. J Am Coll Cardiol. 1997;30:113-118.
13. Woo KS, Robinson JTC, Chook P, Adams MR, Yip G, Mai ZJ, Lam CWK, Sorensen KE, Deanfield JE, Celermajer DS. Differences in the effect of cigarette smoking on endothelial function in Chinese and Caucasian adults. Ann Intern Med. 1997;127:372-375.
14. Chan NN, Colhoun HM, Vallance P. Cardiovascular risk factors as determinants of endothelium-dependent and endothelium-independent vascular reactivity in the general population. J Am Coll Cardiol. 2001; 38:1814-1820.
15. Simon A, Gariepy J, Chironi G, Megnien JL, Levenson J. Intima-media thickness: a new tool for diagnosis and treatment of cardiovascular risk. J Hypertens. 2002;20:159-169.
16. Lakka TA, Lakka HM, Salonen R, Kaplan GA, Salonen JT. Abdominal obesity is associated with accelerated progression of carotid atherosclerosis in men. Atherosclerosis. 2001;154:497-504.
17. Mannami T, Baba S, Ogata J. Strong and significant relationships between aggregation of major coronary risk factors and the acceleration of carotid atherosclerosis in the general population of a Japanese city: the Suita Study. Arch Intern Med. 2000;160:2297-2303.
18. Chan JCN, Cockram CS. Diabetes in the Chinese population and its implications for health care. Diabetes Care. 1997;20:1785-1790.
19. UK Prospective Diabetes Study Group. Intensive blood glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837-853.
20. Woo KS, Chook P, Raitakari OT, McQuillan B, Feng JZ, Celermajer DS. Westernization of Chinese adults and increased subclinical atherosclerosis. Arterioscler Thromb Vasc Biol. 1999;19:2487-2493.
21. Woo KS, Chook P, Chan WB, So WY, Cockram CS, Celermajer DS. Type 1 diabetes and arterial dysfunction in asymptomatic Chinese adults. Diabetes Care. 2001;24:173.
22. Guerci B, Bohme P, Kearney-Schwartz A, Zannad F, Drouin P. Endothelial dysfunction and type 2 diabetes. Part 2: altered endothelial function and the effects of treatments in type 2 diabetes mellitus. Diabetes Metab. 2001;27:436-447.
23. Thomas GN, Critchley JAJH, Tomlinson B, Lee ZSK, Young RP, Chan JCN. Albuminuria and the renin-angiotensin system gene polymorphisms in Type 2 diabetic and in normoglycaemic hypertensive Chinese. Clin Nephrol. 2001;55:7-15.
24. World Health Organization. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997; 20:1183-1197.
25. World Health Organization. The Asia-Pacific perspective: redefining obesity and its treatment. Health Communications, Australia; 2000.
26. Salonen JT, Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb. 1991;11:1245-1249.
27. Kawano H, Motoyama T, Hirashima O, Hirai N, Miyao Y, Sakamoto T, Kugiyama K, Ogawa H, Yasue H. Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. J Am Coll Cardiol. 1999;34:146-154.
28. Marfella R, Nappo F, De Angelis L, Paolisso G, Tagliamonte MR, Giugliano D. Hemodynamic effects of acute hyperglycemia in type 2 diabetic patients. Diabetes Care. 2000;23:658-663.
29. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation. 2001;104:365-372.
30. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med. 1999;340:115-126.
31. Thomas GN, Critchley JAJH, Tomlinson B, Anderson PJ, Lee ZSK, Chan JCN. Obesity, independent of insulin resistance, is a major determinant of blood pressure in normoglycaemic Hong Kong Chinese. Metabolism. 2000;49:1523-1528.
32. De Vriese AS, Verbeuren TJ, Van de Voorde J, Lameire NH, Vanhoutte PM. Endothelial dysfunction in diabetes. Br J Pharmacol. 2000;130: 963-974.
33. Vlassara H, Palace MR. Diabetes and advanced glycation endproducts. J Intern Med. 2002;251:87-101.
34. Chan JCN, Cheung JCK, Lau EMC, Woo J, Chan AYW, Cockram CS. The metabolic syndrome in Hong Kong Chinese. The interrelationships among its components analyzed by structural equation modeling. Diabetes Care. 1996;19:953-959.
35. World Health Organization. Obesity: Preventing and managing the global epidemic. Geneva: World Health Organization; 1998.
36. Celermajer DS, Sorensen KE, Georgakopoulos D, Bull C, Thomas O, Robinson J, Deanfield JE. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 1993;88:2149-2155.
37. MRC/BHF Heart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience. Eur Heart J. 1999;20:725-741.
38. McNeill KL, Fontana L, Russell-Jones DL, Rajman I, Ritter JM, Chowienczyk PJ. Inhibitory effects of low-density lipoproteins from men with type II diabetes on endothelium-dependent relaxation. J Am Coll Cardiol. 2000;35:1622-1627.